跳至主要内容
临床试验/NCT06380491
NCT06380491招募中4 期

Impact of Melatonin Treatment on Blood Pressure Circadian Rhythm, Sleep and Metabolic Variables.

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年6月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
50
试验地点
1
主要终点
Melatonin at a dose of 3 mg before sleep time, after a period of 30 days changes the time awake after sleep onset (WASO), and recovers the dipper pattern of blood pressure

研究概览

简要总结

The goal of this clinical trial is to learn if melatonin works to treat comorbid insomnia in adults with OSA and nocturnal non-dipping blood pressure pattern.

The main question it aims to answer is:

Does melatonin maintain sleep during night and recover the dipping blood pressure pattern?

详细描述

The goal of this clinical trial is to learn if melatonin works to treat comorbid insomnia in adults with OSA and nocturnal non-dipping blood pressure pattern.

The main question it aims to answer is:

Does melatonin maintain sleep during night and recover the dipping blood pressure pattern?

Participants will:

  • Take melatonin or the habitual treatment every day for one month
  • Visit the clinic 11 times for one month
  • Keep a diary of their symptom and activities and use twice a 24 h ambulatory blood pressure monitoring (ABPM), attend two overnight polysomnography studies, and use an actigraph every day for 2 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Polisomnographic diagnosis of Obstructive Sleep Apnea
  • Non-dipping blood pressure on Ambulatory blood pressure monitoring (ABPM):

排除标准

  • Use of sleep or psychiatric medication
  • Use of Positive Airway Pressure (CPAP or Bipap)
  • Neurologic or psychiatric disorder

研究组 & 干预措施

Usual care for nocturnal non-dipping Blood Pressurem in OSA

Experimental

1. Group of participants receives an intervention/treatment considered to be usual care

干预措施: Melatonin 3 MG Oral Tablet (Drug)

Oral administration of 3 mg/day of melatonin for 30 days in non-dipping Blood Pressure in OSA

Experimental

2. Group of participants receives oral Melatonin 3 mg/day during 30 days plus usual care

干预措施: Melatonin 3 MG Oral Tablet (Drug)

结局指标

主要结局

Melatonin at a dose of 3 mg before sleep time, after a period of 30 days changes the time awake after sleep onset (WASO), and recovers the dipper pattern of blood pressure

时间窗: 30 days

Wake after sleep onset (WASO) and non-dipper patter of Blood Pressure change after melatonin intake for 30 days

次要结局

未报告次要终点

研究者

发起方
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matilde Valencia-Flores

Coordinator/ Head of the Sleep Disorders Clinic

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

研究点 (1)

Loading locations...

相似试验

Melatonin's Effect on Nighttime Blood Pressure and... | 临床试验